Proteros Appoints New Chief Financial Officer
News Oct 10, 2012
Arnd Christ has more than 12 years of international experience as a CFO in the biotechnology industry, with responsibilities in finance, operations, legal affairs and investor relations. He has successfully conducted a number of financial transactions and has a broad experience in all aspects of accounting and controlling.
Arnd Christ has a successful track record in various biotechnology companies and has most recently worked as Chief Financial Officer at MediGene AG, a listed biotechnology company in Germany. Formerly he served as CFO in biotechnology companies in Germany and Switzerland, as well as Finance Director within the Hoechst AG Group. Mr. Christ earned his master’s degree in Business Administration at Julius Maximilian University Würzburg.
"I am delighted to be joining such an accomplished management team that has built Proteros into a profitable business" commented Arnd Christ. "I am looking forward to helping the team execute on their growth strategy and in particular, the continued expansion into integrated lead discovery collaborations."
Dr. Torsten Neuefeind, Chief Executive Officer and founder of Proteros, stated: "We are very pleased to have Arnd join Proteros. His extensive international finance experience in Biotech as well as his solid CFO-background will be a valuable skill set to further support Proteros’ growth strategy in the collaborative research business and in higher value lead discovery partnerships."
Researchers Develop New Method to Generate Human AntibodiesNews
Researchers hope their approach will help researchers rapidly generate therapeutic antibodies for the treatment of infectious diseases and other conditions such as cancer.READ MORE
Large-Scale Production of Living Brain Cells Enables Entirely New ResearchNews
After performing a biopsy on the patient, the skin cells are transformed into brain cells that effectively imitate the disease and the age of the patient.READ MORE
U.S. Study of Dapivirine Ring in Lactating Women Finds Little Drug Gets Into Breast MilkNews
The antiretroviral drug dapivirine that is released from an experimental vaginal ring to protect against HIV is absorbed in very low concentrations into breastmilk.READ MORE
Comments | 0 ADD COMMENT
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Target Engagement in Biology and Drug Discovery
Feb 19 - Feb 23, 2018